We provide a wide range of discovery and development services for New Biological Entities (NBEs) from our state-of-the-art facility located in Hyderabad, India. At the core of our large molecule discovery services is a talented team of scientists experienced in the design and delivery of a range of advanced therapeutic modalities such as Monoclonal Antibody (mAb), Antibody Drug Conjugates (ADC), bi-specific antibodies, protein therapeutics, mRNA and CAR-T. We establish and adopt innovative technology platforms for faster, reliable and cost-effective solutions to complex problems throughout the biologics value chain. We have the ability to forward integrate large molecule discovery with clinical manufacturing and beyond.
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.